<DOC>
	<DOCNO>NCT02007603</DOCNO>
	<brief_summary>The study conduct investigate pharmacokinetics ampicillin / sulbactam amoxicillin/clavulanic acid intermittent haemodialysis .</brief_summary>
	<brief_title>Concentration Ampicillin / Sulbactam Amoxicillin / Clavulanic Acid Blood During Renal Replacement Therapy Longterm Renal Replacement Therapy Patients</brief_title>
	<detailed_description />
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Sultamicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>Age &gt; 18 year Suspected proven bacterial infection require parenteral antibiotic therapy . Renal replacement therapy ( HD ) Known hypersensitivity ampicillin / sulbactam , amoxicillin / clavulanic acid betalactames , severe hypersensitivity ( anaphylactic reaction ) betalactam antibacterial agent . An expected survival less two day . Known pregnancy Coadministration one follow drug : probenecid discontinue duration study Ampicillin / sulbactam respectively amoxicillin / clavulanic acid monotherapy resistant specie fungal infection . Other reason oppose study participation discretion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>chronic hemodialysis</keyword>
	<keyword>ampicillin</keyword>
	<keyword>sulbactam</keyword>
	<keyword>amoxicillin</keyword>
	<keyword>clavulanic acid</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>